A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy-Reference-Cited by-同舟云学术

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy

Published:2014-06-16 Issue:1 Volume:11 Page:
ISSN:1743-422X
Container-title:Virology Journal
language:en
Short-container-title:Virol J

Author:

Gu Linlin,Krendelchtchikova Valentina,Krendelchtchikov Alexandre,Oster Robert A,Fujihashi Kohtaro,Matthews Qiana L

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

https://link.springer.com/content/pdf/10.1186/1743-422X-11-112.pdf

Reference56 articles.

1. Matthews QL, Gu L, Krendelchtchikov A, Li ZC: Viral Vectors for Vaccine Development, Novel Gene Therapy Approaches. In Edited by: Ming W. 2013.http://www.intechopen.com/books/novel-gene-therapy-approaches/viral-vectors-for-vaccine-development ISBN: 978-953-51-0966-2, InTech, doi: 10.5772/54700. Available from:

2. Limbach KJ, Richie TL: Viral vectors in malaria vaccine development. Parasite Immunol 2009, 31: 501-519. 10.1111/j.1365-3024.2009.01141.x

3. Robert-Guroff M: Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol 2007, 18: 546-556. 10.1016/j.copbio.2007.10.010

4. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J: Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med 2013, 15: 65-77. 10.1002/jgm.2698

5. Curiel DT: Strategies to adapt adenoviral vectors for targeted delivery. Ann N Y Acad Sci 1999, 886: 158-171. 10.1111/j.1749-6632.1999.tb09409.x

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”;Virologica Sinica;2020-05-26

2. The potential of adenoviral vaccine vectors with altered antigen presentation capabilities;Expert Review of Vaccines;2020-01-02

3. Capsid-Incorporation Strategy To Display Antigens for an Alternative Adenoviral Vector Vaccine Approach;Molecular Pharmaceutics;2018-10-25

4. Progress in Adenoviral Capsid-Display Vaccines;Biomedicines;2018-07-26

5. A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine;PLOS ONE;2016-04-29